Both in Biotechnology
Protalix BioTherapeutics vs ProKidney
Over the past year PLX returned +9.2% and PROK returned −62.5%; their daily moves had a correlation of 0.19.
PLX +9.2% PROK −62.5%Growth of $1, one year, split-adjusted
| Metric | PLX | PROK |
|---|---|---|
| Price | $2.61 | $1.07 |
| Market cap | $210.3M | $223.6M |
| Today | +1.95% | −4.46% |
| 1 month | −3.7% | −32.3% |
| 6 months | +33.2% | −44.3% |
| Year to date | +45.0% | −52.2% |
| 1 year | +10.1% | −65.0% |
| Revenue growth (YoY) | +27.1% | −32.1% |
| Gross margin | 61.0% | 100.0% |
| Net margin | 19.0% | −18948.0% |
| P/E (TTM) | 11.1× | — |
| Price / sales | 2.6× | 273.4× |
| Net cash | $40.7M | $181.6M |
| Dividend yield | — | — |
| Volatility (60d) | 44.8% | 85.3% |
| Short % of float | 4.7% | 27.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).